查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948297

2026年全球外科止血剂市场报告

Surgical Hemostats Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，外科止血器械市场成长显着，预计将从2025年的39.3亿美元成长到2026年的42亿美元，复合年增长率为6.9%。过去几年成长要素包括外科手术数量的增加、对止血的需求、外科器械的进步、医院基础设施的扩建以及患者安全意识的提高。

预计未来几年，外科止血剂市场规模将强劲成长，2030年将达到54.1亿美元，复合年增长率（CAGR）为6.5%。预测期内的成长可归因于止血产品的创新、机器人辅助手术的普及、门诊手术中心的增加、人工智慧在医疗保健领域的应用以及对可生物降解止血剂的需求。预测期内的关键趋势包括微创手术技术、先进止血材料的研发、照护现场止血监测、人工智慧在手术规划中的应用以及环保永续的外科用品。

预计创伤病例的增加将在不久的将来推动外科止血剂市场的成长。创伤是指由于某种事件导致个体身心受到疼痛或伤害，并伴随身体损伤或心理创伤。创伤病例的增加主要是因为交通事故的急剧增加，导致严重伤害需要紧急医疗照护。外科止血剂能够快速有效地控制创伤病例的出血，减少失血量，稳定患者病情，以便进行后续治疗。例如，威斯康辛州卫生服务部报告称，2023年因攻击造成的创伤病例比2022年增加了3%，从1544例增加到1584例。因此，创伤病例的成长趋势正在推动外科止血剂市场的扩张。

主要企业正致力于开发先进的解决方案，例如室温稳定的密封贴片，以改善止血效果、提高手术室效率并克服低温运输储存的挑战。室温密封贴片是新一代止血垫，无需冷藏即可保持其全部功能。与传统的冷藏或笨重的海绵止血贴相比，它们具有更高的柔软性、更快的展开速度和更方便的使用方式。例如，2025年5月，总部位于美国的医疗保健公司百特国际（Baxter International）推出了Hemopatch Sealing Hemostat RT，这是一种新型的胶原蛋白蛋白贴片，旨在为开放性手术手术和微创手术提供有效的止血效果。此贴片结合了可生物降解的牛真皮胶原胶原蛋白基质和一层薄薄的NHS-PEG层，后者在接触体液后会形成水凝胶，从而实现快速的组织黏附和密封，同时支持血小板的自然活性。止血效果可在约两分钟内实现，具有良好的生物相容性，并在六至八週内完全吸收。它还具有实际优势，例如室温储存和长达 36 个月的保质期，从而改善手术工作流程和供应链柔软性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球外科止血剂市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 自主系统、机器人与智慧运输
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
  • 主要趋势
    • 微创手术技术
    • 先进止血材料的研发
    • 床边止血监测
    • 将人工智慧融入手术计划
    • 环保永续的外科耗材

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 创伤中心
  • 门诊手术中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球外科止血剂市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球外科止血剂市场规模、比较及成长率分析
  • 全球外科止血剂市场表现：规模与成长，2020-2025年
  • 全球外科止血剂市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球总潜在市场（TAM）

第九章 市场细分

  • 依产品类型
  • 局部使用凝血酶止血剂、液体止血剂、胶原蛋白止血剂、氧化再生纤维素止血剂、明胶止血剂、复合止血剂及其他产品类型
  • 配方
  • 基质和凝胶止血剂、海绵止血剂、片状和垫状止血剂、粉末止血剂
  • 透过使用
  • 神经外科、整形外科、心血管外科、妇科手术、创伤、整形外科及其他适应症
  • 最终用户
  • 医院、门诊手术中心、专科诊所和其他最终用户
  • 依类型细分：局部用凝血酶类止血剂
  • 人类凝血酶类止血剂、牛凝血酶类止血剂、重组凝血酶类止血剂，剂型：凝胶、喷雾剂、粉末、海绵剂
  • 按类型细分：流动性止血剂
  • 含凝血酶的明胶基质、胶原蛋白基液体止血剂、合成聚合物基液体止血剂
  • 按类型细分：胶原蛋白类止血剂
  • 微纤维胶原胶原蛋白、不织布胶原蛋白垫、胶原蛋白绒或胶原蛋白片
  • 按类型细分：氧化再生纤维素止血剂
  • 织布氧化再生纤维素布、不织布氧化再生纤维素垫、添加剂氧化再生纤维素
  • 按类型细分：明胶类止血剂
  • 明胶海绵、明胶粉、含凝血酶的明胶泡沫
  • 按类型细分：复合止血剂
  • 明胶+凝血酶、胶原蛋白+凝血酶、氧化再生纤维素+凝血酶
  • 按类型细分：其他产品类型
  • 几丁聚醣止血剂、高岭土类止血剂、合成胜肽止血剂、植物来源止血剂

第十章 区域与国家分析

  • 全球外科止血剂市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球外科止血剂市场：依国家、表现及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 外科止血剂市场：竞争格局及市场占有率（2024年）
  • 外科止血剂市场：公司估值矩阵
  • 外科止血剂市场：公司概况
    • Thermo Fisher Scientific Inc
    • Danaher Corporation
    • Agilent Technologies Inc
    • PerkinElmer Inc
    • Mettler Toledo International Inc

第37章：其他领先和创新企业

  • Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes BV, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年外科止血剂市场：提供新机会的国家
  • 2030年外科止血剂市场：充满新机会的细分市场
  • 2030年外科止血剂市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MSHEM01_G26Q1

Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.

The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.

Tariffs have influenced the surgical hemostats market by affecting the cost and availability of raw materials such as collagen, gelatin, and synthetic polymers used in hemostatic products. Increased tariffs have raised production costs, particularly for matrix and gel hemostats, flowable hemostats, and topical thrombin-based hemostats, impacting key regions like North America and Europe where imports are significant. While this has created challenges for manufacturers, it has also encouraged local production and sourcing strategies, potentially reducing dependency on imports and driving innovation in cost-effective hemostat solutions.

The surgical hemostats market research report is one of a series of new reports from The Business Research Company that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. This surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The surgical hemostats market size has grown strongly in recent years. It will grow from $3.93 billion in 2025 to $4.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising surgical procedures, demand for blood loss management, advancement in surgical instruments, increase in hospital infrastructure, awareness about patient safety.

The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to innovation in hemostatic products, adoption of robotic-assisted surgeries, growth in outpatient surgical centers, integration of ai in healthcare, demand for biodegradable hemostats. Major trends in the forecast period include minimally invasive surgical techniques, advanced hemostatic materials development, point-of-care hemostasis monitoring, integration of ai in surgical planning, eco-friendly and sustainable surgical supplies.

The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.

Major companies operating in the surgical hemostat market are concentrating on creating advanced solutions, such as room-temperature-stable sealing patches, to improve bleeding control, optimize operating-room efficiency, and overcome challenges related to cold-chain storage. Room-temperature sealing patches are next-generation hemostatic pads designed to retain full functionality without the need for refrigeration, providing enhanced flexibility, quicker deployment, and better accessibility compared with conventional refrigerated or bulky sponge-based hemostats. For example, in May 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat RT, its newest collagen-based patch developed for effective hemostasis in both open and minimally invasive surgeries. The patch combines a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that forms a hydrogel upon fluid contact, enabling fast tissue adhesion and sealing while supporting natural platelet activity. Achieving hemostasis generally within approximately two minutes, offering biocompatibility, and fully resorbing within 6-8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, enhancing surgical workflow and supply-chain flexibility.

In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Surgical Hemostats Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for surgical hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Topical Thrombin-Based Hemostats; Flowable Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Gelatin-Based Hemostats; Combination Hemostats; Other Product Types
  • 2) By Formulation: Matrix And Gel Hemostats; Sponge Hemostats; Sheet And Pad Hemostats; Powder Hemostats
  • 3) By Application: Neurological Surgery; Orthopedic Surgery; Cardiovascular Surgery; Gynecological Surgery; Trauma; Plastic Surgery; Other Applications
  • 4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats; Bovine Thrombin-Based Hemostats; Recombinant Thrombin-Based Hemostats; Formulations Gel, Spray, Powder, Sponge
  • 2) By Flowable Hemostats: Gelatin Matrix With Thrombin; Collagen-Based Flowables; Synthetic Polymer-Based Flowables
  • 3) By Collagen-Based Hemostats: Microfibrillar Collagen; Nonwoven Collagen Pads; Collagen Fleece Or Sheets
  • 4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric; Non-woven Oxidized Regenerated Cellulose Pads; Oxidized Regenerated Cellulose With Additives
  • 5) By Gelatin-Based Hemostats: Gelatin Sponge; Gelatin Powder; Gelatin Foam With Thrombin
  • 6) By Combination Hemostats: Gelatin + Thrombin; Collagen + Thrombin; Oxidized Regenerated Cellulose + Thrombin
  • 7) By Other Product Types: Chitosan-Based Hemostats; Kaolin-Based Hemostats; Synthetic Peptide Hemostats; Plant-Derived Agents
  • Companies Mentioned: Thermo Fisher Scientific Inc; Danaher Corporation; Agilent Technologies Inc; PerkinElmer Inc; Mettler Toledo International Inc; Shimadzu Corporation; Waters Corporation; Bruker Corporation; HORIBA Ltd; JEOL Ltd; Anton Paar GmbH; Renishaw plc; Metrohm AG; Genedata AG; HunterLab Europe GmbH; Avantes B V; JASCO Corporation; Wasatch Photonics Inc; Lablicate GmbH; StellarNet Inc; LabWare Inc; SciY Software GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Surgical Hemostats Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Surgical Hemostats Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Surgical Hemostats Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Surgical Hemostats Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Minimally Invasive Surgical Techniques
    • 4.2.2 Advanced Hemostatic Materials Development
    • 4.2.3 Point-Of-Care Hemostasis Monitoring
    • 4.2.4 Integration Of Ai In Surgical Planning
    • 4.2.5 Eco-Friendly And Sustainable Surgical Supplies

5. Surgical Hemostats Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Clinics
  • 5.4 Trauma Centers
  • 5.5 Outpatient Surgical Facilities

6. Surgical Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Surgical Hemostats Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Surgical Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Surgical Hemostats Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Surgical Hemostats Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Surgical Hemostats Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Surgical Hemostats Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Surgical Hemostats Market Segmentation

  • 9.1. Global Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types
  • 9.2. Global Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats
  • 9.3. Global Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications
  • 9.4. Global Surgical Hemostats Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
  • 9.5. Global Surgical Hemostats Market, Sub-Segmentation Of Topical Thrombin-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge
  • 9.6. Global Surgical Hemostats Market, Sub-Segmentation Of Flowable Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables
  • 9.7. Global Surgical Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets
  • 9.8. Global Surgical Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives
  • 9.9. Global Surgical Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin
  • 9.10. Global Surgical Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin
  • 9.11. Global Surgical Hemostats Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

10. Surgical Hemostats Market Regional And Country Analysis

  • 10.1. Global Surgical Hemostats Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Surgical Hemostats Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Surgical Hemostats Market

  • 11.1. Asia-Pacific Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Surgical Hemostats Market

  • 12.1. China Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Surgical Hemostats Market

  • 13.1. India Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Surgical Hemostats Market

  • 14.1. Japan Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Surgical Hemostats Market

  • 15.1. Australia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Surgical Hemostats Market

  • 16.1. Indonesia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Surgical Hemostats Market

  • 17.1. South Korea Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Surgical Hemostats Market

  • 18.1. Taiwan Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Surgical Hemostats Market

  • 19.1. South East Asia Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Surgical Hemostats Market

  • 20.1. Western Europe Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Surgical Hemostats Market

  • 21.1. UK Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Surgical Hemostats Market

  • 22.1. Germany Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Surgical Hemostats Market

  • 23.1. France Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Surgical Hemostats Market

  • 24.1. Italy Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Surgical Hemostats Market

  • 25.1. Spain Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Surgical Hemostats Market

  • 26.1. Eastern Europe Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Surgical Hemostats Market

  • 27.1. Russia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Surgical Hemostats Market

  • 28.1. North America Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Surgical Hemostats Market

  • 29.1. USA Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Surgical Hemostats Market

  • 30.1. Canada Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Surgical Hemostats Market

  • 31.1. South America Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Surgical Hemostats Market

  • 32.1. Brazil Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Surgical Hemostats Market

  • 33.1. Middle East Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Surgical Hemostats Market

  • 34.1. Africa Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Surgical Hemostats Market Regulatory and Investment Landscape

36. Surgical Hemostats Market Competitive Landscape And Company Profiles

  • 36.1. Surgical Hemostats Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Surgical Hemostats Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Surgical Hemostats Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. PerkinElmer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Mettler Toledo International Inc Overview, Products and Services, Strategy and Financial Analysis

37. Surgical Hemostats Market Other Major And Innovative Companies

  • Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc

38. Global Surgical Hemostats Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Surgical Hemostats Market

40. Surgical Hemostats Market High Potential Countries, Segments and Strategies

  • 40.1 Surgical Hemostats Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Surgical Hemostats Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Surgical Hemostats Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer